- Home » News and EventsPage 27

NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Updates for media on the latest products, offerings and developments across our business.
Press Releases
The Use Of Continuous Chromatography In Effective Process Design To Be Presented By ̽»¨ºÏ¼¯ Biologics Expert At PREP Symposium
Jul 2, 2019
̽»¨ºÏ¼¯ today announced that Ben Kester, Manager and Senior Scientist, Purification Development, ̽»¨ºÏ¼¯ Biologics, will present at the upcoming 32nd International PREP Symposium.
̽»¨ºÏ¼¯â€™s Partner, Amicus, Announces It Has Entered Into A Strategic Partnership With ̽»¨ºÏ¼¯ For Gene Therapy Development And Manufacturing
Jul 2, 2019
The agreement supports clinical and commercial supply needs for Pompe and other lysosomal disease gene therapy programs
Ways Of Maximizing Value Through Collaborations To Be Discussed By ̽»¨ºÏ¼¯ At ON Helix
Jun 27, 2019
̽»¨ºÏ¼¯ today announced that Rob Harris, Ph.D., Director, Science & Technology will present at the upcoming ON Helix conference to be held at the Babraham Research Campus, Cambridge, U.K. on July 9 – 10, 2019.
Novavax and ̽»¨ºÏ¼¯ Biologics Enter Strategic Partnership with Acquisition of Novavax’ Manufacturing Assets and Capabilities
Jun 27, 2019
Novavax, Inc. and ̽»¨ºÏ¼¯ Biologics’ Paragon Gene Therapy unit today announced an arrangement under which Paragon Gene Therapy will assume the leases to two Novavax product development and manufacturing facilities, giving it immediate access to state-of-the-art…
̽»¨ºÏ¼¯ To Purchase Bristol-Myers Squibb Manufacturing Facility In Anagni, Italy
Jun 19, 2019
Bristol-Myers Squibb Company and ̽»¨ºÏ¼¯, Inc. today announced that ̽»¨ºÏ¼¯ has agreed to purchase Bristol-Myers Squibb’s oral solid, biologics, and sterile product manufacturing and packaging facility in Anagni, Italy.
IVERIC Bio Enters Into Strategic Manufacturing Relationship With ̽»¨ºÏ¼¯â€™s Paragon Gene Therapy For Orphan Inherited Retinal Diseases
Jun 17, 2019
IVERIC bio, Inc. and ̽»¨ºÏ¼¯ Biologics, today announced that they have entered into an agreement for production and manufacturing of GMP-grade adeno-associated virus vector for IVERIC bio’s gene therapy product candidates…
̽»¨ºÏ¼¯ to Launch OneBio Suite for Integrated Biologics Development, Manufacturing and Supply at BIO International 2019
May 23, 2019
̽»¨ºÏ¼¯ is to launch its new OneBio SuiteSM for the integrated development, manufacturing, and clinical supply of biologic drugs at the BIO International Convention
̽»¨ºÏ¼¯ Completes Acquisition of Gene Therapy Leader Paragon Bioservices, Inc. for $1.2 Billion
May 20, 2019
̽»¨ºÏ¼¯, Inc. (NYSE: CTLT) today announced that it has completed the $1.2 billion acquisition of Paragon Bioservices, Inc., a leading viral vector development and manufacturing partner for gene therapies.
̽»¨ºÏ¼¯ Achieves Global ISO Accreditation
May 9, 2019
̽»¨ºÏ¼¯ today announced that the British Standards Institute has awarded ̽»¨ºÏ¼¯ a global accreditation against the international management standards for environment and Occupational Safety.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.